Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-14

Clinical Trial Update: Acamprosate vs. Placebo in Bipolar Alcoholics [Phase 4]

View source ↗

Summary

Phase 4 trial comparing acamprosate to placebo in individuals with alcohol dependence and bipolar disorder; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • acamprosate (acamprosate)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence, Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-12-14